Wakefield Asset Management L »

Corcept Therapeutics Incorporated shares owned by Wakefield Asset Management L

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Wakefield Asset Management L from 13F filings

Historical chart of Wakefield Asset Management L investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Wakefield Asset Management L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Wakefield Asset Management L

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.4M 21k 114.22
2024-12-31 $993k 20k 50.39

More positions owned by Wakefield Asset Management L

Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Core Msci Emkt (IEMG)
JPMorgan Chase & Co. (JPM)
Proshares Tr Short Qqq (PSQ)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Newmont Mining Corporation (NEM)
Alphabet Cap Stk Cl A (GOOGL)
Lam Research Corp Com New (LRCX)
Trane Technologies SHS (TT)
Technipfmc (FTI)

View all positions for Wakefield Asset Management L

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co
Epoch Investment Partners

View all funds holding Corcept Therapeutics Incorporated